Epitope-based universal vaccine for Human T-lymphotropic virus-1 (HTLV-1). [PDF]
PLoS One, 2021 Human T-cell leukemia virus type 1 (HTLV-1) was the first oncogenic human retrovirus identified in humans which infects at least 10–15 million people worldwide. Large HTLV-1 endemic areas exist in Southern Japan, the Caribbean, Central and South America,
Raza MT +4 more
europepmc +4 more sources
Sights set on universal vaccine. [PDF]
New Sci, 2021 Scientists have begun the race to create a single vaccine that protects us from all future coronaviruses, with human trials starting soon, finds Graham Lawton.
Lawton G.
europepmc +4 more sources
Mol Cell Ther, 2018 Background For many deadly viruses, there are no preventive and / or therapeutic vaccines approved by health authorities World-wide (e.g., HIV, Ebola, Dengue, and many others).
Malecki M, Saetre B.
europepmc +5 more sources
Designing a multi-epitope universal vaccine for concurrent infections of SARS-CoV-2 and influenza viruses using an immunoinformatics approach [PDF]
BMC Infectious DiseasesBackground Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) and influenza viruses share several conserved epitopes that can be utilized for the development of universal vaccines.
Shirin Mohammadipour +4 more
doaj +3 more sources
Role of universal and targeted recommendations for vaccines for sexually transmitted infections in the USA, China and Indonesia: a cross-sectional study [PDF]
BMJ Public HealthBackground Vaccines for sexually transmitted infections (STIs) are in development and little is known about their future acceptance. The type of recommendations released by National Immunisation Technical Advisory Groups could influence vaccine uptake ...
Abram L Wagner +3 more
doaj +3 more sources
Influenza and Universal Vaccine Research in China. [PDF]
Viruses, 2022 Influenza viruses usually cause seasonal influenza epidemics and influenza pandemics, resulting in acute respiratory illness and, in severe cases, multiple organ complications and even death, posing a serious global and human health burden. Compared with
Li J, Zhang Y, Zhang X, Liu L.
europepmc +2 more sources
Challenges and developments in universal vaccine design against SARS-CoV-2 variants. [PDF]
NPJ Vaccines, 2022 The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had become a global concern because of its unexpectedly high pathogenicity and transmissibility.
Zhao F, Zai X, Zhang Z, Xu J, Chen W.
europepmc +2 more sources
Challenges for the development of a universal vaccine against leptospirosis revealed by the evaluation of 22 vaccine candidates. [PDF]
Front Cell Infect Microbiol, 2022 Leptospirosis is a neglected disease of man and animals that affects nearly half a million people annually and causes considerable economic losses. Current human vaccines are inactivated whole-cell preparations (bacterins) of Leptospira spp. that provide
Maia MAC +12 more
europepmc +2 more sources
Research Progress of Universal Influenza Vaccine [PDF]
VaccinesInfluenza viruses continue to undergo antigenic drift and shift, resulting in the need to update existing vaccines annually. Therefore, the development of a universal influenza vaccine has become an urgent global need. This paper reviews the functions of
Liangliang Wang +7 more
doaj +3 more sources
Development of NP-Based Universal Vaccine for Influenza A Viruses. [PDF]
Vaccines (Basel)The nucleoprotein (NP) is a vital target for the heterosubtypic immunity of CD8+ cytotoxic T lymphocytes (CTLs) due to its conservation among influenza virus subtypes.
Sayedahmed EE +5 more
europepmc +2 more sources